The MYEOV Monoclonal Antibody (PAC010677) is a valuable tool for researchers studying MYEOV, a protein that plays a key role in cancer development and progression. This antibody, generated using hybridoma technology, specifically targets MYEOV in human samples and is suitable for use in various applications, including Western blot and immunohistochemistry.MYEOV is a promising biomarker in cancer research, with studies indicating its involvement in tumor growth, invasion, and metastasis. By targeting MYEOV with this antibody, researchers can unravel its functions and potential therapeutic implications in various types of cancer.
This antibody provides a reliable means of detecting and analyzing MYEOV expression in tumor tissues, aiding in the understanding of its role in oncogenesis.Overall, the MYEOV Monoclonal Antibody is a valuable asset for investigators exploring the molecular mechanisms of cancer and seeking novel targets for diagnosis and treatment. Its high specificity and sensitivity make it an essential tool for advancing research in oncology and personalized medicine.
